Fluid resuscitation with hydroxyethyl starches in patients with sepsis is associated with an increased incidence of acute kidney injury and use of renal replacement therapy: A systematic review and meta-analysis of the literature

Carregando...
Imagem de Miniatura
Citações na Scopus
83
Tipo de produção
article
Data de publicação
2014
Editora
W B SAUNDERS CO-ELSEVIER INC
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
VEELO, Denise P.
PEIREIRA, Victor Galvao Moura
ASSUNCAO, Murillo Santucci Cesar de
MANETTA, Jose Antonio
ESPOSITO, Daniel Crepaldi
SCHULTZ, Marcus J.
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
JOURNAL OF CRITICAL CARE, v.29, n.1, article ID 185.e1, 7p, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Purpose: Fluid resuscitation is a key intervention in sepsis, but the type of fluids used varies widely. The aim of this meta-analysis is to determine whether resuscitation with hydroxyethyl starches (HES) compared with crystalloids affects outcomes in patients with sepsis. Materials and Methods: Search of MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials up to February 2013. Studies that compared resuscitation with HES versus crystalloids in septic patients, and reported incidence of acute kidney injury (AKI), renal replacement therapy (RRT), transfusion of red blood cell (RBC) or fresh frozen plasma and/or mortality. Three investigators independently extracted data into uniform risk ratio measures. The Grading of Recommendations Assessment, Development and Evaluation framework was used to determine the quality of the evidence. Results: Ten trials (4624 patients) were included. An increased incidence of AKI (risk ratio [RR], 1.24 [95% Confidence Interval {CI}, 1.13-1.36], and need of RRT (RR, 1.36 [95% CI, 1.17-1.57]) was found in patients who received resuscitation with HES. Resuscitation with HES was also associated with increased transfusion of RBC (RR, 1.14 [95% CI, 1.01-1.93]), but not fresh frozen plasma (RR, 1.47 [95% CI, 0.97-2.24]). Furthermore, while intensive care unit mortality (RR, 0.74 [95% CI, 0.43-1.26]), and 28-day mortality (RR, 1.11 [95% CI, 0.96-1.28]) was not different, resuscitation with HES was associated with higher 90-day mortality (RR, 1.14 [95% CI, 1.04-1.26]). Conclusions: Fluid resuscitation practice with HES as in the meta-analyzed studies is associated with increased an increase in AKI incidence, need of RRT, RBC transfusion, and 90-day mortality in patients with sepsis. Therefore, we favor the use of crystalloids over HES for resuscitation in patients with sepsis.
Palavras-chave
Sepsis, Colloid, Crystalloid, Hydroxyethyl starch, Meta-analysis
Referências
  1. Bagshaw SM, 2007, CLIN J AM SOC NEPHRO, V2, P431, DOI 10.2215/CJN.03681106
  2. Bayer O, 2012, CRIT CARE MED, V40, P2543, DOI 10.1097/CCM.0b013e318258fee7
  3. Bellmann R, 2012, CLIN PHARMACOKINET, V51, P225, DOI 10.2165/11594700-000000000-00000
  4. Bouchard J, 2009, KIDNEY INT, V76, P422, DOI 10.1038/ki.2009.159
  5. Boyd JH, 2011, CRIT CARE MED, V39, P259, DOI 10.1097/CCM.0b013e3181feeb15
  6. Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716
  7. Dellinger RP, 2013, INTENS CARE MED, V39, P165, DOI 10.1007/s00134-012-2769-8
  8. Dubin A, 2010, J CRIT CARE, V25, P659, DOI 10.1016/J.JCRC.2010.04.007
  9. Finfer S, 2010, CRIT CARE, V14, DOI 10.1186/cc9293
  10. Finfer S, 2011, INTENS CARE MED, V37, P86, DOI 10.1007/s00134-010-2039-6
  11. Gattas DJ, 2012, ANESTH ANALG, V114, P159, DOI 10.1213/ANE.0b013e318236b4d6
  12. Guidet B, 2012, CRIT CARE, V16, DOI 10.1186/cc11358
  13. Guyatt GH, 2008, BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE
  14. Haase N, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f839
  15. Legrand Matthieu, 2011, Ann Intensive Care, V1, P13, DOI 10.1186/2110-5820-1-13
  16. Lv Jie, 2012, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V24, P38
  17. McIntyre LA, 2008, CAN J ANAESTH, V55, P819, DOI 10.1007/BF03034053
  18. MORAN M, 1987, NEW ENGL J MED, V317, P150, DOI 10.1056/NEJM198707163170306
  19. Myburgh JA, 2012, NEW ENGL J MED, V367, P1901, DOI 10.1056/NEJMoa1209759
  20. Perel P, 2011, COCHRANE DB SYST REV, V3
  21. Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242
  22. Schortgen F, 2001, LANCET, V357, P911, DOI 10.1016/S0140-6736(00)04211-2
  23. Zarychanski R, 2013, JAMA-J AM MED ASSOC, V309, P678, DOI 10.1001/jama.2013.430
  24. Zhu Guo-chao, 2011, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V23, P150